Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety and tolerability of sublingual asenapine in pediatric patients with schizophrenia or Bipolar I Disorder; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Saphris (asenapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia, Bipolar I Disorder | Phase 1 | Status: COMPLETED | Results posted: 2012-12-21